These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28143405)

  • 41. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.
    Norris EH; Uryu K; Leight S; Giasson BI; Trojanowski JQ; Lee VM
    Am J Pathol; 2007 Feb; 170(2):658-66. PubMed ID: 17255333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative evaluation of orofacial motor function in mice: The pasta gnawing test, a voluntary and stress-free behavior test.
    Rabl R; Horvath A; Breitschaedel C; Flunkert S; Roemer H; Hutter-Paier B
    J Neurosci Methods; 2016 Dec; 274():125-130. PubMed ID: 27746230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
    Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
    Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain region-dependent differential expression of alpha-synuclein.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    J Comp Neurol; 2016 Apr; 524(6):1236-58. PubMed ID: 26358191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
    Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
    Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
    Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
    Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
    Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
    Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
    Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
    Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
    Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
    Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.
    Fernagut PO; Hutson CB; Fleming SM; Tetreaut NA; Salcedo J; Masliah E; Chesselet MF
    Synapse; 2007 Dec; 61(12):991-1001. PubMed ID: 17879265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.
    La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
    Wu Q; Yang X; Zhang Y; Zhang L; Feng L
    Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line.
    Delenclos M; Carrascal L; Jensen K; Romero-Ramos M
    Neuroscience; 2014 Sep; 277():647-64. PubMed ID: 25090921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits.
    Hatami A; Chesselet MF
    Curr Top Behav Neurosci; 2015; 22():303-30. PubMed ID: 25218491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging.
    Khairnar A; Ruda-Kucerova J; Szabó N; Drazanova E; Arab A; Hutter-Paier B; Neddens J; Latta P; Starcuk Z; Rektorova I
    Brain Behav Immun; 2017 Mar; 61():197-208. PubMed ID: 27923670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-Synuclein.
    Almandoz-Gil L; Lindström V; Sigvardson J; Kahle PJ; Lannfelt L; Ingelsson M; Bergström J
    Cell Mol Neurobiol; 2017 Oct; 37(7):1217-1226. PubMed ID: 28028735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
    Rockenstein E; Mallory M; Hashimoto M; Song D; Shults CW; Lang I; Masliah E
    J Neurosci Res; 2002 Jun; 68(5):568-78. PubMed ID: 12111846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.